S

The original guidelines recommended that autogenous
AV access be constructed in at least 50% of all new renal
failure patients electing to receive hemodialysis as their
initial form of renal replacement therapy, with the expectation that ultimately, 40% of prevalent patients would be
receiving their hemodialysis through an autogenous AV
access.11 The 2006 updated KDOQI Guidelines raised this
benchmark for minimal use of autogenous access